237 related articles for article (PubMed ID: 33236093)
1. Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining.
Luo J; Zhang W; Su C; Zhou Z; Wang G
Nephrol Dial Transplant; 2021 Dec; 36(12):2216-2223. PubMed ID: 33236093
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Characteristics and Outcomes of PLA
Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
[TBL] [Abstract][Full Text] [Related]
3. The association of serum anti-PLA2R antibody and glomerular PLA2R antigen staining with clinical manifestations and outcomes in membranous nephropathy.
Yang SF; Xie XF; Lu WH; Lan P; Liu H; Jin L
Clin Exp Nephrol; 2023 Dec; 27(12):1060-1066. PubMed ID: 37668806
[TBL] [Abstract][Full Text] [Related]
4. The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy.
Chen Y; Xu Y; Chen S; Yu Y; Zhu X; Chen J
Ren Fail; 2023; 45(2):2264939. PubMed ID: 37814415
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies.
Li X; Shen Y; Li Y; Ma L; Sun Q
Ren Fail; 2024 Dec; 46(1):2297015. PubMed ID: 38275176
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the status of phospholipase A2 receptor and prognosis of idiopathic membranous nephropathy.
Li YQ; Liu ZZ; Lin KX; Liu RH; Ni L; Liu GX; Lan HY; Shi YJ
Nephrology (Carlton); 2020 Feb; 25(2):144-149. PubMed ID: 31226230
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
9. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.
Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB
BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003
[TBL] [Abstract][Full Text] [Related]
10. A cohort study of membranous nephropathy, primary or secondary.
Arghiani M; Zamani BH; Nazemian F; Samadi S; Afsharian MS; Habibzadeh M; Eslami S; Sabbagh MG
BMC Nephrol; 2021 Apr; 22(1):138. PubMed ID: 33874909
[TBL] [Abstract][Full Text] [Related]
11. The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification.
Hu X; Wang X; Yu X; Ni L; Gao C; Pan X; Ren H; Xu J; Ma J
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202076
[TBL] [Abstract][Full Text] [Related]
12. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
[TBL] [Abstract][Full Text] [Related]
13. Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy.
Qin HZ; Zhang MC; Le WB; Ren Q; Chen DC; Zeng CH; Liu L; Zuo K; Xu F; Liu ZH
J Am Soc Nephrol; 2016 Oct; 27(10):3195-3203. PubMed ID: 26989120
[TBL] [Abstract][Full Text] [Related]
14. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
15. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy.
Xie Q; Li Y; Xue J; Xiong Z; Wang L; Sun Z; Ren Y; Zhu X; Hao CM
Am J Nephrol; 2015; 41(4-5):345-53. PubMed ID: 26087695
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
[TBL] [Abstract][Full Text] [Related]
17. Membranous nephropathy-diagnosis and identification of target antigens.
Sethi S; Fervenza FC
Nephrol Dial Transplant; 2024 Mar; 39(4):600-606. PubMed ID: 37863839
[TBL] [Abstract][Full Text] [Related]
18. Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy.
Liu Z; Wan C; Cao Y; Liu S; Xu Z; Zhang C; Su H
J Nephrol; 2024 Jan; 37(1):149-158. PubMed ID: 37882962
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of renal biopsy in anti-phospholipase A2 receptor antibody-positive patients with proteinuria in China.
Lu S; Xiao J; Liu D; Zhang Y; Dong Y; Zhao Z
Sci Rep; 2024 Feb; 14(1):2907. PubMed ID: 38316889
[TBL] [Abstract][Full Text] [Related]
20. [Role of M-type phospholipase A2 receptor and its antibody in hepatitis B virus-associated membranous nephropathy].
Xu X; Zhu X; Yuan S; Jiang W; Xia Y; Liu H; Li J; Sun L; Peng Y; Liu F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1064-1068. PubMed ID: 27807329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
